Novartis Ag (NVS) Other Non-Current Assets (2009 - 2026)

Novartis Ag's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $200.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $200.0 million; the TTM figure through Mar 2026 stood at $200.0 million (changed N/A YoY), while the FY2025 annual figure was $509.0 million, down 85.48% from the prior year.
• Other Non-Current Assets came in at $200.0 million for Q1 2026 at Novartis Ag, down from $509.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.5 billion in Q2 2025 to a low of $200.0 million in Q1 2026.
• A 5-year average of $2.0 billion and a median of $1.2 billion in 2023 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets jumped 303.64% in 2022 and sank 85.48% in 2025, its largest moves.
• Novartis Ag's Other Non-Current Assets stood at $1.1 billion in 2022, then gained by 8.02% to $1.2 billion in 2023, then soared by 192.33% to $3.5 billion in 2024, then tumbled by 85.48% to $509.0 million in 2025, then slumped by 60.71% to $200.0 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $200.0 million, $509.0 million, and $4.5 billion for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison